Impact of Oral Hygiene Gels on Peri-implant Mucositis
Primary Purpose
Mucositis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Livionex gel
Aquafresh gel
Sponsored by
About this trial
This is an interventional treatment trial for Mucositis
Eligibility Criteria
Inclusion Criteria:
- history of 5 mm+ pocket bleeding on probing around implant
Exclusion Criteria:
- dental treatment of implant in previous 30 days
- Sjogrens disease
- immunodeficiencies (e.g. AIDS)
- poorly-controlled diabetes
- regular use of antibiotics, anti-inflammatory drugs or immune suppressants
Sites / Locations
- University of Nebraska Medical Center, College of Dentistry
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Livionex gel
Aquafresh gel
Arm Description
Brushing area of mucositis with Livionex gel for 30 days
Brushing area of mucositis with Aquafresh gel for 30 days
Outcomes
Primary Outcome Measures
Gingival Index
Level of clinical inflammation around dental implant
Secondary Outcome Measures
Plaque Index
Amount of biofilm around dental implant
Crevicular Fluid Biomarkers
Fluid from around implant measured for inflammation markers with ELISA
Full Information
NCT ID
NCT03243591
First Posted
August 4, 2017
Last Updated
September 22, 2023
Sponsor
University of Nebraska
1. Study Identification
Unique Protocol Identification Number
NCT03243591
Brief Title
Impact of Oral Hygiene Gels on Peri-implant Mucositis
Official Title
Impact of Oral Hygiene Gels on Peri-implant Mucositis
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
August 22, 2017 (Actual)
Primary Completion Date
March 15, 2018 (Actual)
Study Completion Date
July 1, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Nebraska
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Peri-implant mucositis is abnormal inflammation occurring around dental implants, increasing the risk of loss of bone support. The purpose of this study is to evaluate the impact of brushing the bacterial biofilm at the implant-mucosa interface with one of two, commercially-available dental gels over a 30-day period on amounts of biofilm and indices of mucosal inflammation. Adult subjects (> 19 years old) will be invited to consent if they have at least one dental implant displaying mucositis defined as Gingivitis Index of 2 or greater, no dental treatment in the previous 30 days, capable of normal toothbrushing, and no Sjogrens disease, immunodeficiency, pregnancy, poorly-controlled diabetes, or regular systemic antibiotics, anti-inflammatory drugs or immune suppressants. Ten patients in each tooth gel group will be instructed to apply a pea size amount of dentifrice brushing the implant and mucosa 2 times daily for 30 days. Baseline and 30-day examinations will be conducted to record Gingivitis Index, Plaque Index, probing depths, clinical photo, crevicular fluid, and adverse events.
Detailed Description
This will be a prospective, randomized, controlled, double-blind, single center study. Once eligibility has been determined, up to 21 Subjects will be enrolled. Subjects will be randomly assigned in a 1:1 ratio to treat with either Livionex Dental Gel (a plaque control gel that is safe for ingestion and is currently sold by Livionex Inc.) or the control Aquafresh toothpaste. Each study visit will last 30 minutes.
The soft tissue around the dental implant will be observed at baseline and after 30 days for inflammation using the Gingivitis Index and probed with a UNC 15 periodontol probe for pocket depth and bleeding. A photograph will be taken of the most inflamed side of the implant. Plaque will be stained with oral hygiene staining rinse and evaluated for Plaque Index. Finally, a paper strip will be inserted between the gingiva and implant on facial and lingual sides for 30 seconds each.
GINGIVITIS INDEX: Gingivitis score (GI)= Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation slight change in color and little change in texture 2 = Moderate inflammation moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding. GI scored=sum of GI scores divided by the number of sites (gingival gum line around the tooth) scored.
PLAQUE INDEX Using Quigley Staining Hein Method with Turesky Modification:Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth. Plaque score = sum of all scores divided by the number of sites (teeth) scored.
Each patients will be instructed to brush around the implant with a pea size amount of dentifrice provided, twice daily for 30 days.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mucositis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
prospective, randomized, controlled, double-blind, single center
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Gels are in coded opaque tubes created at the manufacturer
Allocation
Randomized
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Livionex gel
Arm Type
Active Comparator
Arm Description
Brushing area of mucositis with Livionex gel for 30 days
Arm Title
Aquafresh gel
Arm Type
Active Comparator
Arm Description
Brushing area of mucositis with Aquafresh gel for 30 days
Intervention Type
Other
Intervention Name(s)
Livionex gel
Other Intervention Name(s)
Aquafresh gel
Intervention Description
Brushing area of mucositis with gel
Intervention Type
Other
Intervention Name(s)
Aquafresh gel
Intervention Description
Aquafresh gel
Primary Outcome Measure Information:
Title
Gingival Index
Description
Level of clinical inflammation around dental implant
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Plaque Index
Description
Amount of biofilm around dental implant
Time Frame
30 days
Title
Crevicular Fluid Biomarkers
Description
Fluid from around implant measured for inflammation markers with ELISA
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
history of 5 mm+ pocket bleeding on probing around implant
Exclusion Criteria:
dental treatment of implant in previous 30 days
Sjogrens disease
immunodeficiencies (e.g. AIDS)
poorly-controlled diabetes
regular use of antibiotics, anti-inflammatory drugs or immune suppressants
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard A Reinhardt, DDS
Organizational Affiliation
University of Nebraska
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Nebraska Medical Center, College of Dentistry
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68583
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Impact of Oral Hygiene Gels on Peri-implant Mucositis
We'll reach out to this number within 24 hrs